當(dāng)前位置：首頁(yè) JCRQ2 期刊介紹(非官網(wǎng))

Ophthalmology And TherapySCIE

國(guó)際簡(jiǎn)稱：OPHTHALMOL THER 參考譯名：眼科和治療

中科院分區(qū)
3區(qū)
CiteScore分區(qū)
Q2
JCR分區(qū)
Q2

基本信息：: ISSN：2193-8245; E-ISSN：2193-6528; 是否OA：開(kāi)放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：ENGLAND; 出版商：SPRINGER INTERNATIONAL PUBLISHING AG; 出版語(yǔ)言：English; 出版周期：6 issues per year; 研究方向：OPHTHALMOLOGY

評(píng)價(jià)信息：: 影響因子：2.6; CiteScore指數(shù)：4.2; SJR指數(shù)：1.16; SNIP指數(shù)：1.28

發(fā)文數(shù)據(jù)：: Gold OA文章占比：99.79%; 研究類文章占比：81.63%; 年發(fā)文量：196; 自引率：0.0303...; 開(kāi)源占比：0.9973; 出版撤稿占比：0; 出版國(guó)人文章占比：0.02; OA被引用占比：1

投稿咨詢加急見(jiàn)刊

英文簡(jiǎn)介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見(jiàn)問(wèn)題

英文簡(jiǎn)介Ophthalmology And Therapy期刊介紹

Ophthalmology And Therapy is an open access, peer-reviewed (single-blind), fast-publishing international journal. The scope of the journal is broad and will consider all scientifically sound research, from preclinical, clinical (all stages), observational, real-world and health outcome studies, around the use of ophthalmic therapies, devices and surgical techniques.

The journal is of interest to a broad range of pharmaceutical and healthcare professionals and publishes short newsletters such as original studies, reviews, case reports/series, trial protocols, and reviews and editorials. Ophthalmology and treatment will consider all scientifically sound studies, whether positive, confirmed or negative data. Submissions are welcome regardless of whether they reach an international and/or country-specific audience, which is crucial when researchers are trying to target more specific patient groups. This inclusive approach allows the journal to assist in disseminating high-quality research, which may be considered of insufficient interest by other journals.

期刊簡(jiǎn)介Ophthalmology And Therapy期刊介紹

《Ophthalmology And Therapy》是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個(gè)領(lǐng)域的原創(chuàng)研究提供一個(gè)展示平臺(tái)，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵(lì)先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見(jiàn)解，或?qū)彶槎嗄陙?lái)某個(gè)重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時(shí)報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時(shí)間： 6 Weeks
醫(yī)學(xué)
OPHTHALMOLOGY
SCIE
中科院3區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Ophthalmology And Therapy Cite Score數(shù)據(jù)

CiteScore：4.2
SJR：1.158
SNIP：1.28

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Ophthalmology	Q2	39 / 137	71%

CiteScore 是由Elsevier(愛(ài)思唯爾)推出的另一種評(píng)價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫(kù)中收集的引文為基礎(chǔ)，針對(duì)的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評(píng)價(jià)期刊影響力的方法，而不僅僅是通過(guò)影響因子(IF)這一單一指標(biāo)來(lái)評(píng)價(jià)。

歷年Cite Score趨勢(shì)圖

中科院SCI分區(qū)Ophthalmology And Therapy 中科院分區(qū)

中科院 2023年12月升級(jí)版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	3區(qū)	OPHTHALMOLOGY 眼科學(xué)	3區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計(jì)量學(xué)方法對(duì)國(guó)際、國(guó)內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級(jí)劃分的期刊評(píng)價(jià)標(biāo)準(zhǔn)。它為我國(guó)科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評(píng)價(jià)國(guó)際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國(guó)各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個(gè)層次，類似于“優(yōu)、良、及格”等。最開(kāi)始，這個(gè)分區(qū)只是為了方便圖書(shū)管理及圖書(shū)情報(bào)領(lǐng)域的研究和期刊評(píng)估。之后中科院分區(qū)逐步發(fā)展成為了一種評(píng)價(jià)學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢(shì)圖

JCR分區(qū)Ophthalmology And Therapy JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：OPHTHALMOLOGY	SCIE	Q2	26 / 95	73.2%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：OPHTHALMOLOGY	SCIE	Q2	31 / 95	67.89%

JCR分區(qū)的優(yōu)勢(shì)在于它可以幫助讀者對(duì)學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評(píng)估。不同學(xué)科的文章引用量可能存在較大的差異，此時(shí)單獨(dú)依靠影響因子(IF)評(píng)價(jià)期刊的質(zhì)量可能是存在一定問(wèn)題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢(shì)圖

發(fā)文數(shù)據(jù)

2023-2024 年國(guó)家/地區(qū)發(fā)文量統(tǒng)計(jì)

國(guó)家/地區(qū)數(shù)量
USA76
England48
Greece19
Italy17
Switzerland15
GERMANY (FED REP GER)14
Japan8
Canada7
India7
Spain7

本刊中國(guó)學(xué)者近年發(fā)表論文

1、Nonsurgical Management of Severe Viral Keratitis with Hypopyon and Retrocorneal Plaques: A Case Series
Author: Yang, Zhen; Yu, Shuo; Zhang, Chun; Agrawal, Rupesh; Feng, Yun

Journal: OPHTHALMOLOGY AND THERAPY. 2023; Vol. 12, Issue 1, pp. 599-611. DOI: 10.1007/s40123-022-00592-x
2、The Double-Deck Viscoelastic Technique: a Novel Surgical Technique to Protect the Corneal Endothelium in Penetrating Keratoplasty of Aphakic Silicone Oil-Dependent Eyes after Severe Ocular Injury
Author: Cen, Yujie; Zhang, Mingzhou; Lu, Yao; Feng, Yun

Journal: OPHTHALMOLOGY AND THERAPY. 2023; Vol. 12, Issue 1, pp. 613-623. DOI: 10.1007/s40123-022-00594-9
3、Determination of Vascular Endothelial Growth Factor-B Concentrations in Aqueous Humor and Plasma of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy Patients Before and After Anti-VEGF Therapy
Author: Zhou, Huiying; Zhao, Xinyu; Wang, Shuran; Chen, Youxin

Journal: OPHTHALMOLOGY AND THERAPY. 2023; Vol. 12, Issue 2, pp. 827-837. DOI: 10.1007/s40123-022-00618-4
4、Clinical Feasibility and Safety of Scleral Collagen Cross-Linking by Riboflavin and Ultraviolet A in Pathological Myopia Blindness: A Pilot Study
Author: Li, Yu; Qi, Yue; Sun, Mingshen; Zhai, Changbin; Wei, Wenbin; Zhang, Fengju

Journal: OPHTHALMOLOGY AND THERAPY. 2023; Vol. 12, Issue 2, pp. 853-866. DOI: 10.1007/s40123-022-00633-5
5、Evaluation of Multimodal Biometric Parameters for Diagnosing Acute Angle Closure Secondary to Lens Subluxation
Author: Chen, Xi; Song, Qinglu; Yan, Wen; Wang, Zijin; Cai, Bin; Zhang, Ying; Zhong, Hua; Chen, Qin

Journal: OPHTHALMOLOGY AND THERAPY. 2023; Vol. 12, Issue 2, pp. 839-851. DOI: 10.1007/s40123-022-00638-0
6、Using Artificial Intelligence to Analyse the Retinal Vascular Network: The Future of Cardiovascular Risk Assessment Based on Oculomics? A Narrative Review
Author: Arnould, Louis; Meriaudeau, Fabrice; Guenancia, Charles; Germanese, Clement; Delcourt, Cecile; Kawasaki, Ryo; Cheung, Carol Y.; Creuzot-Garcher, Catherine; Grzybowski, Andrzej

Journal: OPHTHALMOLOGY AND THERAPY. 2023; Vol. 12, Issue 2, pp. 657-674. DOI: 10.1007/s40123-022-00641-5
7、Deep Learning for the Detection of Multiple Fundus Diseases Using Ultra-widefield Images
Author: Sun, Gongpeng; Wang, Xiaoling; Xu, Lizhang; Li, Chang; Wang, Wenyu; Yi, Zuohuizi; Luo, Huijuan; Su, Yu; Zheng, Jian; Li, Zhiqing; Chen, Zhen; Zheng, Hongmei; Chen, Changzheng

Journal: OPHTHALMOLOGY AND THERAPY. 2023; Vol. 12, Issue 2, pp. 895-907. DOI: 10.1007/s40123-022-00627-3
8、Effect of Myopic Undercorrection on Habitual Reading Distance in Schoolchildren: The Hong Kong Children Eye Study
Author: Tang, Shu Min; Zhang, Xiu Juan; Wang, Yu Meng; Zhang, Yuzhou; Wong, Lok Man; Chan, Hei-Nga; Zhang, Bi Ning; Chu, Wai Kit; Kam, Ka Wai; Young, Alvin L. L.; Tham, Clement C. C.; Chen, Li Jia; French, Amanda N. N.; Rose, Kathryn A. A.; Pang, Chi Pui; Yam, Jason C. C.

Journal: OPHTHALMOLOGY AND THERAPY. 2023; Vol. 12, Issue 2, pp. 925-938. DOI: 10.1007/s40123-022-00628-2